Shire, Takeda reach breakthrough in $64 billion deal talks
LONDON/NEW YORK (Reuters) – London-listed drugmaker Shire Plc said on Tuesday it was willing to recommend to its shareholders a deal with Takeda Pharmaceutical Co, after the Japanese company sweetened its acquisition offer...
Read More